Alentis Therapeutics funding
Alentis Therapeutics funding profile: $366M total raised. Latest round: Series D. Backed by OrbiMed, Novo Holdings, Jeito Capital.
Headquarters: Basel, Switzerland
Investors
- OrbiMed
- Novo Holdings
- Jeito Capital
- Frazier Life Sciences
- Longitude Capital
Fundraising guides
Browse the company funding database · Browse investors · Fundraising library
